Spondyloarthritis Clinical Trial
Official title:
Phase II Study of 99mTc-rhAnnexin V-128 Radionuclide Imaging in Patients With Clinical Suspicion or Confirmed Diagnosis of Spondyloarthritis (SpA)
This single center, open-label, proof of concept (PoC) Phase II study aimed to assess the
investigational imaging agent 99mTc-rhAnnexin V-128 in detecting spondyloarthritis (SpA)
lesions.
Overall, it was planned to recruit 20 adults with suspected or confirmed SpA. First, 5
patients were enrolled into a "proof of concept" phase, to assess the imaging potential of
99mTc-rhAnnexin V-128 in terms of imaging quality, disease-lesion radiotracer uptake and
medical relevance. Based on these results the Data Monitoring Committee (DMC) was to decide
whether to terminate the study or whether to continue and enroll the next 15 planned
patients.
The study was prematurely terminated by the sponsor after the first 5 patients completed the
PoC phase based on strategic considerations.
Novartis acquired Advanced Accelerator Applications SA.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03564743 -
Description of Spondylarthritis and Validation of ASAS Criteria in West Indian Patients Seen in Consultation of Rheumatology.
|
||
Completed |
NCT01219257 -
Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting Biological Therapy
|
||
Recruiting |
NCT05433168 -
Study Evaluating the Effectiveness of Shiatsu on Fatigue in Patients With Axial Spondyloarthritis
|
N/A | |
Recruiting |
NCT05039216 -
Biobank for Inflammatory Chronic Diseases and Osteoporosis
|
||
Completed |
NCT04483648 -
Cervical Stabilization Exercises in Patients With Spondyloarthritis
|
N/A | |
Recruiting |
NCT04602091 -
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
|
||
Not yet recruiting |
NCT04077957 -
Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs
|
Phase 4 | |
Recruiting |
NCT05290363 -
The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial Spondyloarthritis
|
N/A | |
Not yet recruiting |
NCT05006690 -
Telerehabilitation, Face-to-Face and Home-Based Spinal Stabilization Exercise Training in Patients With Spondyloarthritis
|
N/A | |
Completed |
NCT02998398 -
Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital
|
||
Completed |
NCT02148640 -
The NOR-SWITCH Study
|
Phase 4 | |
Completed |
NCT01174186 -
Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing
|
Phase 4 | |
Recruiting |
NCT04499001 -
Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skills for Patients With Inflammatory Arthritis With Subcutaneous Biologic DMARDs
|
||
Completed |
NCT03253796 -
Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)
|
Phase 4 | |
Active, not recruiting |
NCT04169373 -
A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis
|
Phase 3 | |
Recruiting |
NCT04292067 -
Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
|
||
Completed |
NCT04946539 -
Value of Ultrasonographic Enthesitis Assessment in Spondyloarthritis
|
||
Recruiting |
NCT03983473 -
Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease.
|
N/A | |
Terminated |
NCT03345355 -
MRI of Sacroiliac Joints: Evaluation of Accuracy of Dixon Sequences in the Diagnosis of Axial Spondyloarthritis
|
||
Completed |
NCT04360785 -
Effect of Two Methotrexate in Sync With the First Adalimumab to Prevent the Immunisation Anti Ada in Spondyloarthritis
|
N/A |